BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 28314289)

  • 1. Dose-dense Paclitaxel- and Carboplatin-based Neoadjuvant Chemotherapy Followed by Surgery or Concurrent Chemo-radiotherapy in Cervical Cancer: a Preliminary Analysis.
    Gadducci A; Barsotti C; Laliscia C; Cosio S; Fanucchi A; Tana R; Fabrini MG
    Anticancer Res; 2017 Mar; 37(3):1249-1255. PubMed ID: 28314289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of neoadjuvant chemotherapy and radical hysterectomy for locally advanced cervical cancer at Kigali University Teaching Hospital, Rwanda: a retrospective descriptive study.
    Ngabonziza E; Ghebre R; DeBoer RJ; Ntasumbumuyange D; Magriples U; George J; Grover S; Bazzett-Matabele L
    BMC Womens Health; 2024 Mar; 24(1):204. PubMed ID: 38555423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dense neoadjuvant chemotherapy before radical surgery in cervical cancer: a retrospective cohort study and systematic literature review.
    Caruso G; Bruni S; Lapresa M; De Vitis LA; Parma G; Minicucci V; Betella I; Schivardi G; Peccatori F; Lazzari R; Cliby W; Aletti GD; Zanagnolo V; Maggioni A; Colombo N; Multinu F
    Int J Gynecol Cancer; 2023 Nov; ():. PubMed ID: 37949488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy plus surgery versus concurrent chemoradiotherapy in stage IB2-IIB cervical cancer: A systematic review and meta-analysis.
    Zou W; Han Y; Zhang Y; Hu C; Feng Y; Zhang H; Wang J
    PLoS One; 2019; 14(11):e0225264. PubMed ID: 31725793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful neoadjuvant chemotherapy plus sintilimab for locally advanced cervical cancer: case series and review of the literature.
    Liu L; Deng X; Guo S; Yang S
    Diagn Pathol; 2023 Sep; 18(1):107. PubMed ID: 37752528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To compare neoadjuvant concurrent chemo-radiotherapy followed by surgery and neoadjuvant chemotherapy followed by surgery in carcinoma esophagus patients: A single institutional study in the Indian population.
    Purkayastha A; Sharma N; Sundaram V; Jaiswal P; Husain A
    J Cancer Res Ther; 2023; 19(3):675-683. PubMed ID: 37470593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized Phase III Study Comparing Neoadjuvant Chemotherapy Followed by Surgery Versus Chemoradiation in Stage IB2-IIB Cervical Cancer: EORTC-55994.
    Kenter GG; Greggi S; Vergote I; Katsaros D; Kobierski J; van Doorn H; Landoni F; van der Velden J; Reed N; Coens C; van Luijk I; Colombo N; Steen-Banasik EV; Ottevanger N; Casado A;
    J Clin Oncol; 2023 Nov; 41(32):5035-5043. PubMed ID: 37656948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy Analysis of Neoadjuvant versus Adjuvant Cisplatin-Paclitaxel Regimens for Initial Treatment of FIGO Stages IB3 and IIA2 Cervical Cancer.
    Tao W; Wang W; Zhai J; Guo L
    Med Sci Monit; 2023 Dec; 29():e940545. PubMed ID: 38062672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early regression index (ERI) on MR images as response predictor in esophageal cancer treated with neoadjuvant chemo-radiotherapy: Interim analysis of the prospective ESCAPE trial.
    Fiorino C; Palumbo D; Mori M; Palazzo G; Pellegrini AE; Albarello L; Belardo A; Canevari C; Cossu A; Damascelli A; Elmore U; Mazza E; Pavarini M; Passoni P; Puccetti F; Slim N; Steidler S; Del Vecchio A; Di Muzio NG; Chiti A; Rosati R; De Cobelli F
    Radiother Oncol; 2024 May; 194():110160. PubMed ID: 38369025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized Study to Evaluate Efficacy and Toxicity Profile of Paclitaxel-carboplatin as Neo-adjuvant Chemotherapy in Locally Advanced Supraglottic and Hypopharyngeal Primaries.
    Vats P; Suhag V; Chakravarty N; Vashisth R; Jain M
    Indian J Otolaryngol Head Neck Surg; 2023 Jun; 75(2):366-373. PubMed ID: 37275084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Fifteen-Gene Classifier to Predict Neoadjuvant Chemotherapy Responses in Patients with Stage IB to IIB Squamous Cervical Cancer.
    Tian X; Wang X; Cui Z; Liu J; Huang X; Shi C; Zhang M; Liu T; Du X; Li R; Huang L; Gong D; Tian R; Cao C; Jin P; Zeng Z; Pan G; Xia M; Zhang H; Luo B; Xie Y; Li X; Li T; Wu J; Zhang Q; Chen G; Hu Z
    Adv Sci (Weinh); 2021 May; 8(10):2001978. PubMed ID: 34026427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI Plain Scan: A Tool in the Management of Cervical Cancer during Pregnancy.
    Gao F; Qian T; Sun M; Lu Y; Cheng J; Fu L
    Curr Med Imaging; 2024; 20():1-8. PubMed ID: 38389369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statement of the Uterus Commission of the Gynecological Oncology Working Group (AGO) on Neoadjuvant Chemotherapy Prior to Definitive Radiochemotherapy in Patients with Locally Advanced Cervical Cancer.
    Tempfer C; Fehm T; Vordermark D; Marnitz-Schulze S; Beckmann MW; Denschlag D; Brucker S; Wallwiener M; Eichbaum M; Ataseven B; Hillemanns P;
    Geburtshilfe Frauenheilkd; 2024 Jun; 84(6):523-528. PubMed ID: 38884027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Malignant Brenner tumor with very good response after chemotherapy: about a case and review of the literature].
    El Youbi MB; M'rabti H; Mohtaram A; Aaribi I; Kharmoum J; El Khannoussi B; Errihani H
    Pan Afr Med J; 2014; 17():293. PubMed ID: 25328589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term eradication of locally recurrent invasive follicular thyroid carcinoma after taxane-based concomitant chemoradiotherapy.
    Tulloch-Reid M; Skarulis MC; Sherman SI; Sarlis NJ; Santarpia L
    Anticancer Res; 2009 Nov; 29(11):4665-71. PubMed ID: 20032418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Machine learning for genetic prediction of chemotherapy toxicity in cervical cancer.
    Guo L; Wang W; Xie X; Wang S; Zhang Y
    Biomed Pharmacother; 2023 May; 161():114518. PubMed ID: 36906972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A Case of Adenocarcinoma, HPV-independent, Mesonephric Type with Significant Response to Neoadjuvant Chemotherapy].
    Kuratsune K; Ueda T; Tajiri R; Tohyama A; Hoshino K; Harada H; Kurita T; Kubo C; Komatsu K; Shiba E; Matsuura Y; Yoshino K
    J UOEH; 2024; 46(1):45-51. PubMed ID: 38479874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Study of Neoadjuvant Chemotherapy Followed by Definitive Chemoradiotherapy Versus Definitive Chemoradiotherapy Alone in Locally Advanced Carcinoma of Cervix.
    Tripathi A; Rawat S
    J Obstet Gynaecol India; 2019 Dec; 69(6):546-552. PubMed ID: 31844371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant Weekly Paclitaxel-Carboplatin Is Effective in Stage I-II Cervical Cancer.
    Salihi R; Leunen K; Moerman P; Amant F; Neven P; Vergote I
    Int J Gynecol Cancer; 2017 Jul; 27(6):1256-1260. PubMed ID: 28574931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of neoadjuvant chemotherapy followed by chemoradiation in locally advanced cervical cancer.
    de Azevedo CRAS; Thuler LCS; de Mello MJG; de Oliveira Lima JT; da Fonte ALF; Fontão DFS; Carneiro VCG; Chang TMC; Ferreira CG
    Gynecol Oncol; 2017 Sep; 146(3):560-565. PubMed ID: 28709705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.